The rocky road to translation in spinal cord repair

Annals of Neurology

Volumn 72, Issue 4, 2012, Pages 491-501

  Filli, Linard ^a   Schwab, Martin E ^a  

^a University of Zurich Brain Research Institute   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ATI 355; CETHRIN; METHYLPREDNISOLONE; MINOCYCLINE; NEUROTROPHIC FACTOR; NOGO A ANTIBODY; RILUZOLE; UNCLASSIFIED DRUG;

AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; CERVICAL SPINAL CORD INJURY; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFICACY; EARLY DIAGNOSIS; EXPERIMENTAL THERAPY; HUMAN; NERVE CELL GROWTH; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE PLANNING; PRIORITY JOURNAL; PROGNOSIS; QUADRIPLEGIA; RATING SCALE; REVIEW; SCHWANN CELL; SPINAL CORD INJURY; SPINAL CORD SURGERY; STANDARDIZATION; STEM CELL TRANSPLANTATION; TREATMENT INDICATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; NEUROSURGICAL PROCEDURES; PROGNOSIS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME;

EID: 84868098365     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23630     Document Type: Review

References (132)

1. Schwab ME, Caroni P,. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci 1988; 8: 2381-2393.
2. Oohira A, Matsui F, Katoh-Semba R,. Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. J Neurosci 1991; 11: 822-827.
3. Kottis V, Thibault P, Mikol D, et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 2002; 82: 1566-1569.
4. Silver J, Miller JH,. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146-156.
5. Sun F, He Z,. Neuronal intrinsic barriers for axon regeneration in the adult CNS. Curr Opin Neurobiol 2010; 20: 510-518.
6. Norenberg MD, Smith J, Marcillo A,. The pathology of human spinal cord injury: defining the problems. J Neurotrauma 2004; 21: 429-440.
7. Bunge RP, Puckett WR, Becerra JL, et al. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993; 59: 75-89.
8. Tator CH, Duncan EG, Edmonds VE, et al. Neurological recovery, mortality and length of stay after acute spinal cord injury associated with changes in management. Paraplegia 1995; 33: 254-262.
9. Vilensky JA, Moore AM, Eidelberg E, Walden JG,. Recovery of locomotion in monkeys with spinal cord lesions. J Mot Behav. 1992; 24: 288-296.
10. Rossignol S, Frigon A,. Recovery of locomotion after spinal cord injury: some facts and mechanisms. Annu Rev Neurosci 2011; 34: 413-440.
11. Dietz V,. Neuronal plasticity after a human spinal cord injury: positive and negative effects. Exp Neurol 2012; 235: 110-115.
12. Tator CH,. Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery 2006; 59: 957-982; discussion 982-987.
13. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG,. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 2008; 25: E14.
14. Baptiste DC, Fehlings MG,. Update on the treatment of spinal cord injury. Prog Brain Res 2007; 161: 217-233.
15. Hurlbert RJ, Hamilton MG,. Methylprednisolone for acute spinal cord injury: 5-year practice reversal. Can J Neurol Sci 2008; 35: 41-45.
16. Finch L, Barbeau H, Arsenault B,. Influence of body weight support on normal human gait: development of a gait retraining strategy. Phys Ther 1991; 71: 842-855; discussion 855-856.
17. Wirz M, Zemon DH, Rupp R, et al. Effectiveness of automated locomotor training in patients with chronic incomplete spinal cord injury: a multicenter trial. Arch Phys Med Rehabil 2005; 86: 672-680.
18. Lucareli PR, Lima MO, Lima FP, et al. Gait analysis following treadmill training with body weight support versus conventional physical therapy: a prospective randomized controlled single blind study. Spinal Cord 2011; 49: 1001-1007.
19. Steeves JD, Zariffa J, Kramer JL,. Are you "tilting at windmills" or undertaking a valid clinical trial? Yonsei Med J 2011; 52: 701-716.
20. Philip M, Benatar M, Fisher M, Savitz SI,. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke 2009; 40: 577-581.
21. Barbeau H, Rossignol S,. Recovery of locomotion after chronic spinalization in the adult cat. Brain Res 1987; 412: 84-95.
22. Barbeau H, Rossignol S,. Initiation and modulation of the locomotor pattern in the adult chronic spinal cat by noradrenergic, serotonergic and dopaminergic drugs. Brain Res 1991; 546: 250-260.
23. Courtine G, Gerasimenko Y, van den Brand R, et al. Transformation of nonfunctional spinal circuits into functional states after the loss of brain input. Nat Neurosci 2009; 12: 1333-1342.
24. Fedirchuk B, Nielsen J, Petersen N, Hultborn H,. Pharmacologically evoked fictive motor patterns in the acutely spinalized marmoset monkey (Callithrix jacchus). Exp Brain Res 1998; 122: 351-361.
25. Feraboli-Lohnherr D, Barthe JY, Orsal D,. Serotonin-induced activation of the network for locomotion in adult spinal rats. J Neurosci Res 1999; 55: 87-98.
26. Forssberg H, Grillner S,. The locomotion of the acute spinal cat injected with clonidine i.v. Brain Res 1973; 50: 184-186.
27. Ichiyama RM, Gerasimenko YP, Zhong H, et al. Hindlimb stepping movements in complete spinal rats induced by epidural spinal cord stimulation. Neurosci Lett 2005; 383: 339-344.
28. Harkema S, Gerasimenko Y, Hodes J, et al. Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study. Lancet 2011; 377: 1938-1947.
29. Kerr FW,. Neuroplasticity of primary afferents in the neo-natal cat and some results of early deafferentation of the trigeminal spinal nucleus. J Comp Neurol 1975; 163: 305-327.
30. Fouad K, Pedersen V, Schwab ME, Brosamle C,. Cervical sprouting of corticospinal fibers after thoracic spinal cord injury accompanies shifts in evoked motor responses. Curr Biol 2001; 11: 1766-1770.
31. Ballermann M, Fouad K,. Spontaneous locomotor recovery in spinal cord injured rats is accompanied by anatomical plasticity of reticulospinal fibers. Eur J Neurosci 2006; 23: 1988-1996.
32. Courtine G, Song B, Roy RR, et al. Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nat Med 2008; 14: 69-74.
33. Metz GA, Curt A, van de Meent H, et al. Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. J Neurotrauma 2000; 17: 1-17.
34. Steeves JD, Kramer JK, Fawcett JW, et al. Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. Spinal Cord 2011; 49: 257-265.
35. Wirz M, Bastiaenen C, de Bie R, Dietz V,. Effectiveness of automated locomotor training in patients with acute incomplete spinal cord injury: a randomized controlled multicenter trial. BMC Neurol 2011; 11: 60.
36. Hurlbert RJ,. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine (Phila Pa 1976) 2001; 26 (24 suppl): S39-S46.
37. O'Collins VE, Macleod MR, Donnan GA, et al. 1,026 experimental treatments in acute stroke. Ann Neurol 2006; 59: 467-477.
38. Kwon BK, Hillyer J, Tetzlaff W,. Translational research in spinal cord injury: a survey of opinion from the SCI community. J Neurotrauma 2010; 27: 21-33.
39. Stirling DP, Khodarahmi K, Liu J, et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 2004; 24: 2182-2190.
40. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW,. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003; 126: 1628-1637.
41. Schwartz G, Fehlings MG,. Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg 2001; 94: 245-256.
42. Nogradi A, Szabo A, Pinter S, Vrbova G,. Delayed riluzole treatment is able to rescue injured rat spinal motoneurons. Neuroscience 2007; 144: 431-438.
43. Hollis ER Jr, Jamshidi P, Low K, et al. Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation. Proc Natl Acad Sci U S A 2009; 106: 7215-7220.
44. Liu Y, Kim D, Himes BT, et al. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 1999; 19: 4370-4387.
45. Schnell L, Schneider R, Kolbeck R, et al. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 1994; 367: 170-173.
46. Liu K, Lu Y, Lee JK, et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 2010; 13: 1075-1081.
47. Miao T, Wu D, Zhang Y, et al. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J Neurosci 2006; 26: 9512-9519.
48. Sun F, Park KK, Belin S, et al. Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 2011; 480: 372-375.
49. Bradbury EJ, Moon LD, Popat RJ, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636-640.
50. Freund P, Schmidlin E, Wannier T, et al. Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med 2006; 12: 790-792.
51. Galtrey CM, Asher RA, Nothias F, Fawcett JW,. Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair. Brain 2007; 130: 926-939.
52. GrandPré T, Li S, Strittmatter SM,. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002; 417: 547-551.
53. Schnell L, Schwab ME,. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990; 343: 269-272.
54. Liebscher T, Schnell L, Schnell D, et al. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 2005; 58: 706-719.
55. Dergham P, Ellezam B, Essagian C, et al. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 2002; 22: 6570-6577.
56. Lord-Fontaine S, Yang F, Diep Q, et al. Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury. J Neurotrauma 2008; 25: 1309-1322.
57. Fehlings MG, Theodore N, Harrop J, et al. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J Neurotrauma 2011; 28: 787-796.
58. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011; 28: 1611-1682.
59. Raisman G,. Use of Schwann cells to induce repair of adult CNS tracts. Rev Neurol (Paris) 1997; 153: 521-525.
60. Imaizumi T, Lankford KL, Waxman SG, et al. Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci 1998; 18: 6176-6185.
61. Kohama I, Lankford KL, Preiningerova J, et al. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 2001; 21: 944-950.
62. Ruff CA, Wilcox JT, Fehlings MG,. Cell-based transplantation strategies to promote plasticity following spinal cord injury. Exp Neurol 2012; 235: 78-90.
63. Ankeny DP, McTigue DM, Jakeman LB,. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol 2004; 190: 17-31.
64. Cizkova D, Novotna I, Slovinska L, et al. Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J Neurotrauma 2011; 28: 1951-1961.
65. Saberi H, Moshayedi P, Aghayan HR, et al. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 2008; 443: 46-50.
66. Lima C, Escada P, Pratas-Vital J, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair 2010; 24: 10-22.
67. Chernykh ER, Stupak VV, Muradov GM, et al. Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med 2007; 143: 543-547.
68. Rapalino O, Lazarov-Spiegler O, Agranov E, et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998; 4: 814-821.
69. Bomstein Y, Marder JB, Vitner K, et al. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J Neuroimmunol 2003; 142: 10-16.
70. Jones LA, Lammertse DP, Charlifue SB, et al. A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: pragmatics, recruitment, and demographics. Spinal Cord 2010; 48: 798-807.
71. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30: 2752-2758.
72. Courtine G, Bunge MB, Fawcett JW, et al. Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med 2007; 13: 561-566.
73. Dietz V, Harkema SJ,. Locomotor activity in spinal cord-injured persons. J Appl Physiol 2004; 96: 1954-1960.
74. Duysens J, Van de Crommert HW,. Neural control of locomotion: the central pattern generator from cats to humans. Gait Posture 1998; 7: 131-141.
75. Sacrey LA, Alaverdashvili M, Whishaw IQ,. Similar hand shaping in reaching-for-food (skilled reaching) in rats and humans provides evidence of homology in release, collection, and manipulation movements. Behav Brain Res 2009; 204: 153-161.
76. Pettersson LG,. Forelimb movements in the cat: kinetic features and neuronal control. Acta Physiol Scand Suppl 1990; 594: 1-60.
77. Dietz V, Curt A,. Neurological aspects of spinal-cord repair: promises and challenges. Lancet Neurol 2006; 5: 688-694.
78. Gensel JC, Tovar CA, Hamers FP, et al. Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J Neurotrauma 2006; 23: 36-54.
79. McKinley W, Santos K, Meade M, Brooke K,. Incidence and outcomes of spinal cord injury clinical syndromes. J Spinal Cord Med 2007; 30: 215-224.
80. Anderson KD,. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 2004; 21: 1371-1383.
81. Fawcett JW, Curt A, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007; 45: 190-205.
82. Musienko P, van den Brand R, Marzendorfer O, et al. Controlling specific locomotor behaviors through multidimensional monoaminergic modulation of spinal circuitries. J Neurosci 2011; 31: 9264-9278.
83. Brustein E, Rossignol S,. Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat: II. Effects of noradrenergic and serotoninergic drugs. J Neurophysiol 1999; 81: 1513-1530.
84. Filli L, Zörner B, Weinmann O, Schwab ME,. Motor deficits and recovery in rats with unilateral spinal cord hemisection mimic the Brown-Sequard syndrome. Brain 2011; 134: 2261-2273.
85. Tarlov IM, Klinger H,. Spinal cord compression studies: II. Time limits for recovery after acute compression in dogs. AMA Arch Neurol Psychiatry 1954; 71: 271-290.
86. Basso DM, Beattie MS, Bresnahan JC,. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
87. Kunkel-Bagden E, Dai HN, Bregman BS,. Methods to assess the development and recovery of locomotor function after spinal cord injury in rats. Exp Neurol 1993; 119: 153-164.
88. Zörner B, Filli L, Starkey ML, et al. Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents. Nat Methods 2010; 7: 701-708.
89. Felix ER, Widerstrom-Noga EG,. Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain. J Rehabil Res Dev 2009; 46: 69-83.
90. Kramer JK, Taylor P, Steeves JD, Curt A,. Dermatomal somatosensory evoked potentials and electrical perception thresholds during recovery from cervical spinal cord injury. Neurorehabil Neural Repair 2010; 24: 309-317.
91. Nakae A, Nakai K, Yano K, et al. The animal model of spinal cord injury as an experimental pain model. J Biomed Biotechnol 2011; 2011: 939023.
92. Zörner B, Blanckenhorn WU, Dietz V, Curt A,. Clinical algorithm for improved prediction of ambulation and patient stratification after incomplete spinal cord injury. J Neurotrauma 2010; 27: 241-252.
93. Fehlings MG, Tator CH,. An evidence-based review of decompressive surgery in acute spinal cord injury: rationale, indications, and timing based on experimental and clinical studies. J Neurosurg 1999; 91: 1-11.
94. Cohen-Adad J, Descoteaux M, Rossignol S, et al. Detection of multiple pathways in the spinal cord using q-ball imaging. Neuroimage 2008; 42: 739-749.
95. Cohen-Adad J, El Mendili MM, Lehericy S, et al. Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI. Neuroimage 2011; 55: 1024-1033.
96. Curt A, Dietz V,. Electrophysiological recordings in patients with spinal cord injury: significance for predicting outcome. Spinal Cord 1999; 37: 157-165.
97. Scivoletto G, Di Donna V,. Prediction of walking recovery after spinal cord injury. Brain Res Bull 2009; 78: 43-51.
98. Kramer J, Steeves JD, Curt A,. Sensory segmental assessments following spinal cord injury: significance for care and clinical trials. Top Spinal Cord Inj Rehabil 2009; 14:23-33.
99. Lubieniecka JM, Streijger F, Lee JH, et al. Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats. PLoS One 2011; 6: e19247.
100. Burns AS, Lee BS, Ditunno JF Jr, Tessler A,. Patient selection for clinical trials: the reliability of the early spinal cord injury examination. J Neurotrauma 2003; 20: 477-482.
101. Tuszynski MH, Steeves JD, Fawcett JW, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord 2007; 45: 222-231.
102. Kramer JLK, Lammertse DP, Schubert M, et al. Relationship between motor recovery and independence after sensorimotor complete cervical spinal cord injury. Neurorehabil Neural Repair (in press).
103. Marino RJ, Ditunno JF Jr, Donovan WH, Maynard F Jr,. Neurologic recovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Systems. Arch Phys Med Rehabil 1999; 80: 1391-1396.
104. Zariffa J, Kramer JL, Fawcett JW, et al. Characterization of neurological recovery following traumatic sensorimotor complete thoracic spinal cord injury. Spinal Cord 2011; 49: 463-471.
105. Curt A, Schwab ME, Dietz V,. Providing the clinical basis for new interventional therapies: refined diagnosis and assessment of recovery after spinal cord injury. Spinal Cord 2004; 42: 1-6.
106. Steeves JD, Lammertse D, Curt A, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord 2007; 45: 206-221.
107. Alexander MS, Anderson KD, Biering-Sorensen F, et al. Outcome measures in spinal cord injury: recent assessments and recommendations for future directions. Spinal Cord 2009; 47: 582-591.
108. Chafetz RS, Vogel LC, Betz RR, et al. International standards for neurological classification of spinal cord injury: training effect on accurate classification. J Spinal Cord Med 2008; 31: 538-542.
109. Waring WP III, Biering-Sorensen F, Burns S, et al. 2009 review and revisions of the international standards for the neurological classification of spinal cord injury. J Spinal Cord Med 2010; 33: 346-352.
110. Schuld C, Wiese J, Hug A, et al. Computer implementation of the international standards for neurological classification of spinal cord injury for consistent and efficient derivation of its subscores including handling of data from not testable segments. J Neurotrauma 2012; 29: 453-461.
111. Steeves JD, Lammertse DP, Kramer JLK, et al. Outcome measures for acute/subacute cervical sensorimotor complete (AIS-A) spinal cord injury during a phase 2 clinical trial. Top Spinal Cord Inj Rehabil 2012; 18:1-14.
112. Wolf S, Loose T, Schablowski M, et al. Automated feature assessment in instrumented gait analysis. Gait Posture 2006; 23: 331-338.
113. Kalsi-Ryan S, Beaton D, Curt A, et al. The Graded Redefined Assessment of Strength Sensibility and Prehension: reliability and validity. J Neurotrauma 2012; 29: 905-914.
114. Zariffa J, Kapadia N, Kramer J, et al. Relationship between clinical assessments of function and measurements from an upper-limb robotic rehabilitation device in cervical spinal cord injury. IEEE Trans Neural Syst Rehabil Eng 2012; 20: 341-350.
115. Schlaeger R, D'Souza M, Schindler C, et al. Prediction of long-term disability in multiple sclerosis. Mult Scler 2012; 18: 31-38.
116. Blesch A, Tuszynski MH,. Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci 2009; 32: 41-47.
117. Lammertse D, Tuszynski MH, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord 2007; 45: 232-242.
118. Oudega M, Vargas CG, Weber AB, et al. Long-term effects of methylprednisolone following transection of adult rat spinal cord. Eur J Neurosci 1999; 11: 2453-2464.
119. Holtz A, Nystrom B, Gerdin B,. Effect of methylprednisolone on motor function and spinal cord blood flow after spinal cord compression in rats. Acta Neurol Scand 1990; 82: 68-73.
120. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411.
121. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277: 1597-1604.
122. Tsai EC, Krassioukov AV, Tator CH,. Corticospinal regeneration into lumbar gray matter correlates with locomotor recovery after complete spinal cord transection and repair with peripheral nerve grafts, fibroblast growth factor 1, fibrin glue, and spinal fusion. J Neuropathol Exp Neurol 2005; 64: 230-244.
123. Houle JD, Tom VJ, Mayes D, et al. Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci 2006; 26: 7405-7415.
124. Barros TE, Oliveira R, Barros EM, et al. The use of peripheral nerve bridges to spinal cord injury. J Spinal Cord Med 2003; 26: 33-37.
125. Cheng H, Liao KK, Liao SF, et al. Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine (Phila Pa 1976) 2004; 29: E284-E288.
126. Mackay-Sim A, Feron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008; 131: 2376-2386.
127. Sykova E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15: 675-687.
128. Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 2007; 25: 2066-2073.
129. Dietz V, Colombo G, Jensen L, Baumgartner L,. Locomotor capacity of spinal cord in paraplegic patients. Ann Neurol 1995; 37: 574-582.
130. Stewart JE, Barbeau H, Gauthier S,. Modulation of locomotor patterns and spasticity with clonidine in spinal cord injured patients. Can J Neurol Sci 1991; 18: 321-332.
131. Battistuzzo CR, Callister RJ, Callister R, Galea MP,. A systematic review of exercise training to promote locomotor recovery in animal models of spinal cord injury. J Neurotrauma 2012; 29: 1600-1613.
132. Fouad K, Tetzlaff W,. Rehabilitative training and plasticity following spinal cord injury. Exp Neurol 2012; 235: 91-99.